Breast Cancer Stem Cells Secrete MIF to Mediate Tumor Metabolic Reprogramming That Drives Immune Evasion.
Linlin YanMingming WuTianyu WangHui YuanXiao ZhangHuafeng ZhangTao LiVijay PandeyXinghua HanPeter E LobieTao ZhuPublished in: Cancer research (2024)
MIF secreted by breast cancer stem cells induces metabolic reprogramming in bulk tumor cells and engenders an immunosuppressive microenvironment, identifying MIF targeting as a strategy to improve immunotherapy efficacy in breast cancer.